Back to Authors

Lin, Yi

https://orcid.org/0000-0003-0282-2414

A5016610534 | I1330342723

Mayo Clinic

Citations 32

The CAR-Hematotox Score Identifies Patients at High Risk for Hematological Toxicity, Infections and Poor Clinical Outcomes Following Brexucabtagene Autoleucel in Relapsed/Refractory Mantle Cell Lymphoma

Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 651-653

10.1182/blood-2022-167329

Prognosis Score for Overall Survival with CAR-T Therapy in Aggressive Lymphoma

Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9504-9505

10.1182/blood-2022-167622

Persistance or Reappearance of Serum Monoclonal Protein Detected By Mass Spectrometry Is a Major Prognostic Factor in Patients with Newly Diagnosed Multiple Myeloma

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 2347-2348

10.1182/blood-2022-167430

Outcomes of Multiple Myeloma Patients Refractory to Standard Dose Vs Low Dose Lenalidomide

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9998-9999

10.1182/blood-2022-160368

CAR-T Prescriber Preferences in Adolescents and Young Adults with B-ALL

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 12762-12763

10.1182/blood-2022-163390

Outcomes of Relapsed Refractory Double Hit Lymphoma: A Multicenter Observational Cohort

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 10391-10393

10.1182/blood-2022-159725

Evidence Supporting Light Chain Cast Nephropathy As a Myeloma Defining Event

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 10068-10070

10.1182/blood-2022-162754

Real-World Impact of Time from Leukapheresis to Infusion (Vein-to-Vein Time) in Patients with Relapsed or Refractory (r/r) Large B-Cell Lymphoma (LBCL) Treated with Axicabtagene Ciloleucel

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 7512-7515

10.1182/blood-2022-155603

Patients with Monoclonal Gammopathy Have a High Rate of Second Symptomatic COVID-19 Infection Even after a Prior COVID-19 Infection and Vaccination

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 10017-10019

10.1182/blood-2022-167181

Outpatient Practice Pattern for Recently Approved CAR-T in Patients with Lymphoma and Multiple Myeloma

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 2399-2401

10.1182/blood-2022-167187